美国和英国的一项联合研究显示,长期接受胰岛素增敏剂噻唑烷二酮类药物治疗的糖尿病患者,罹患肺炎或下呼吸道感染的风险升高。论文发表于《胸》(Thorax)5月刊。研究者从两个大型数据库(MEDLINE和EMBASE)、监管性文件及临床试验登记文件数据库中,搜索随机对照研究进行系统回顾分析,共纳 A joint study between the United States and the United Kingdom shows that patients with diabetes who have been on long-term thiazolidinediones, an insulin sensitizer, have a higher risk of developing pneumonia or lower respiratory tract infections. The paper is published in the May issue of Thorax. The researchers systematically reviewed and searched for randomized controlled studies from two large databases (MEDLINE and EMBASE), regulatory documents, and clinical trials registry files